Karen Krasney G.'s most recent trade in Capricor Therapeutics Inc was a trade of 60,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Capricor Therapeutics Inc | Karen G. Krasney | EVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
Capricor Therapeutics Inc | Karen G. Krasney | EVP, GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. | 13 Dec 2024 | 8,000 | 28,047 (0%) | 0% | 1.4 | 11,120 | Common Stock |
Capricor Therapeutics Inc | Karen G. Krasney | EVP, GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2024 | 5,000 | 0 | - | - | Stock Option (Right to Buy) | |
Capricor Therapeutics Inc | Karen G. Krasney | EVP, GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2024 | 3,000 | 0 | - | - | Stock Option (Right to Buy) | |
Capricor Therapeutics Inc | Karen Krasney G. | EVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
Capricor Therapeutics Inc | G. Krasney Karen | EVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 7,140 | 7,140 | - | - | Stock Option (Right to Buy) | |
Capricor Therapeutics Inc | Karen G. Krasney | EVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
Capricor Therapeutics Inc | Karen G. Krasney | EVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 11,878 | 11,878 | - | - | Stock Option (Right to Buy) | |
Capricor Therapeutics Inc | Karen G. Krasney | EVP, GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2022 | 18,932 | 0 | - | - | Stock Option (Right to Buy) | |
Capricor Therapeutics Inc | Karen G. Krasney | EVP, GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. | 03 Nov 2022 | 18,932 | 20,047 (0%) | 0% | 1.4 | 26,315 | Common Stock |
Capricor Therapeutics Inc | Karen G. Krasney | EVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 84,080 | 84,080 | - | - | Stock Option (Right to Buy) | |
Capricor Therapeutics Inc | Karen G. Krasney | EVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 95,693 | 95,693 | - | - | Stock Option (Right to Buy) | |
Capricor Therapeutics Inc | Karen G. Krasney | EVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 104,908 | 104,908 | - | - | Stock Option (Right to Buy) |